ZNTL
Zentalis Pharmaceuticals Llc
2.70$
-1.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | – | – | – | – | – | 100.0% | – | |
| – | – | – | – | – | – | 1.9% | – | |
| 100.0% | – | – | – | – | – | 100.0% | – | |
| 135,150.0% | – | – | – | – | – | 248.8% | – | |
| 34,828.6% | – | – | – | – | – | 129.2% | – | |
| 169,978.6% | – | – | – | – | – | 383.6% | – | |
| -169,878.6% | – | – | – | – | – | -283.6% | – | |
| 0.0% | – | – | – | – | – | – | – | |
| -167,342.9% | – | – | – | – | – | -245.7% | – | |
| 28.6% | – | – | – | – | – | 0.3% | – | |
| -150,478.6% | – | – | – | – | – | -246.0% | – | |
| -169,514.3% | – | – | – | – | – | -276.1% | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.